Abiopharma

🔍 BRANDICOURT OLIVIER (Director)

Company: Vaxcyte, Inc. (PCVX)

Report Date: 2026-01-15

Detailed Transactions and Holdings:

• Acquired 1,357 shares of Common Stock (Direct)
  Date: 2026-01-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,505.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,750 shares of Stock Option (right to buy) at $48.04 per share (Derivative)
  Date: 2026-01-15 | Code: A | Expires: 2035-06-12 | equity_swap_involved: 0 | shares_owned_after: 6,750.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
• F2: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.